Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 61 AL 75

Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease

Vitek GE, Decourt B, Sabbagh MN.

Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28.

Myeloid Cells As a Promising Target for Brain-Bone Degenerative Diseases from a Metabolic Point of View

Pang Y, Zhu S, Xu J, Su C, Wu B, Zhang C, Gao J.

Adv Biol (Weinh). 2023 Oct;7(10):e2200321. doi: 10.1002/adbi.202200321. Epub 2023 Feb 7.

Local and Systemic Hypoxia as Inductors of Increased Aluminum and Iron Brain Accumulation Promoting the Onset of Alzheimer's Disease

Cirovic A, Cirovic A, Orisakwe OE, Lima RR.

Biol Trace Elem Res. 2023 Nov;201(11):5134-5142. doi: 10.1007/s12011-023-03599-y. Epub 2023 Feb 9.

The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease

Sahlgren Bendtsen KM, Hall VJ.

Cells. 2023 Jan 27;12(3):420. doi: 10.3390/cells12030420.

The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?

Takasugi N, Komai M, Kaneshiro N, Ikeda A, Kamikubo Y, Uehara T.

Cells. 2023 Jan 31;12(3):454. doi: 10.3390/cells12030454.

Natural Inhibitors of Cholinesterases: Chemistry, Structure-Activity and Methods of Their Analysis

Smyrska-Wieleba N, Mroczek T.

Int J Mol Sci. 2023 Feb 1;24(3):2722. doi: 10.3390/ijms24032722.

A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease

Peitzika SC, Pontiki E.

Molecules. 2023 Jan 21;28(3):1084. doi: 10.3390/molecules28031084.

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease

Deng M, Yan W, Gu Z, Li Y, Chen L, He B.

Molecules. 2023 Feb 3;28(3):1486. doi: 10.3390/molecules28031486.

Aducanumab for the treatment of Alzheimer's disease: a systematic review

Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM.

Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.

Elucidating the promising role of traditional Chinese medicine in neuroprotection against oxidative stress encompassing Alzheimer's disease

Arora A, Behl T, Sehgal A, Singh S, Sharma N, Abdellatif AAH, Dailah HG, Bhatia S, Al-Harrasi A, Aleya L, Bungau S.

Environ Sci Pollut Res Int. 2023 Mar;30(14):39546-39557. doi: 10.1007/s11356-023-25800-4. Epub 2023 Feb 15.

Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring

Roughley M, Mena C, Howard R, Reeves S, Bertrand J.

Br J Clin Pharmacol. 2023 Jul;89(7):2316-2321. doi: 10.1111/bcp.15692. Epub 2023 Feb 28.

Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint

Kushwah S, Maurya NS, Kushwaha S, Scotti L, Chawade A, Mani A.

Curr Neuropharmacol. 2023;21(4):764-776. doi: 10.2174/1570159X21666230216094353.

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y.

Clin Transl Sci. 2023 May;16(5):810-822. doi: 10.1111/cts.13490. Epub 2023 Feb 26.

Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: evidence from Italian real-world data

Padovani A, Falato S, Pegoraro V.

Curr Med Res Opin. 2023 Apr;39(4):567-577. doi: 10.1080/03007995.2023.2182530. Epub 2023 Mar 11.

Research progress of natural products and their derivatives against Alzheimer's disease

Liu JY, Guo HY, Quan ZS, Shen QK, Cui H, Li X.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2171026. doi: 10.1080/14756366.2023.2171026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias